Skip to main content
. Author manuscript; available in PMC: 2017 Feb 3.
Published in final edited form as: Clin Hemorheol Microcirc. 2012;55(2):205–212. doi: 10.3233/CH-2012-1622

Table 3.

Hematological and hemorheological parameters in SCA patients categorized according to retinopathy severity

Group 1 (n=9) Group 2 (n=16) Group 3 (n=7)
Leukocytes (109/l) 8.41 ± 1.83 9.89 ± 3.36 9.94 ± 2.83
RBCs (1012/l) 3.02 ± 0.78 2.83 ± 0.67 2.75 ± 0.35
Hb (g/100 ml) 8.46 ± 1.26 8.42 ± 1.61 8.96 ± 0.99
MCV (fl) 81.66 ± 13.51 83.63 ± 6.08 90.74 ± 6.92
MCH (pg) 28.99 ± 5.51 30.16 ± 2.55 32.74 ± 2.78
Platelets count (109/l) 370.78 ± 112.98 344.56 ± 129.92 405.29 ± 143.30
Polynuclear Neutrophils (109/l) 4.18 ± 1.29 4.97 ± 1.91 5.53 ± 2.82
Eosinophils (109/l) 0.27 ± 0.15 0.33 ± 0.23 0.30 ± 0.18
Lymphocytes (109/l) 2.91 ± 0.63 3.27 ± 1.27 2.93 ± 1.24
Monocytes (109/l) 0.99 ± 0.33 1.23 ± 0.59 1.11 ± 0.35
Reticulocytes (%) 6.90 ± 2.47 7.61 ± 2.47 8.70 ± 3.44
Lactate dehydrogenase (UI/l) 440.44 ± 104.98 480.14 ± 136.76 437.33 ± 136.59
Hct (%) 26.41 ± 3.92 26.01 ± 5.61 26.50 ± 4.70
ηb at 90s−1(mPa/s 9.03 ± 2.59 7.21 ± 2.00 8.29 ± 2.69
EI at 0.95 Pa 0.06 ± 0.03 0.05 ± 0.04 0.05 ± 0.04
EI at 1.69 Pa 0.12 ± 0.04 0.10 ± 0.05 0.11 ± 0.05
EI at 3 Pa 0.19 ± 0.05 0.15 ± 0.06 0.17 ± 0.06
EI at 5.33 Pa 0.26 ± 0.06 0.22 ± 0.08 0.23 ± 0.07
EI at 9.49 Pa 0.32 ± 0.07 0.28 ± 0.10 0.30 ± 0.09
EI at 16.87 Pa 0.38 ± 0.08 0.32 ± 0.11 0.36 ± 0.10
EI at 30 Pa 0.42 ± 0.09 0.36 ± 0.11 0.40 ± 0.11
AI (%) 57.96 ± 8.03 52.51 ± 7.31 53.75 ± 11.39
γthr (s−1) 258.89 ± 81.50 268.20 ± 120.51 346.43 ± 251.29

Group 1: without sickle cell retinopathy, group 2: non-proliferative and proliferative stage I and II retinopathy, group 3: proliferative retinopathy of stage III, IV and V. Mean ± SD. RBCs = red blood cells, Hb = hemoglobin concentration, MCV = mean corpuscular volume, MCH = mean corpuscular hemoglobin, Hct = hematocrit, ηb = whole blood viscosity, EI = Elongation Index (i.e. RBC deformability), AI = RBC aggregation index, γthr = RBC disaggregation threshold.